NVB-333

N/A

Report date: 2025/11/17 16:53:47
NME

Base Information

Drug NameNVB-333
Drug Alias Namedeoxyactagardine B analogs (Cantab)recombinant proteins (Novacta)NVB-333Nov-0203Nov-203
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovacta Biosystems Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovacta Biosystems LtdCantab Biopharmaceuticals
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A